Page 77 - 2020Taiwan Food and Drug Administration Annual Report
P. 77
'JHVSF c "1&$ .FEJDBM %FWJDFT 3FHVMBUPSZ 4DJFODF $FOUFS PG &YDFMMFODF 1JMPU 8PSLTIPQ
th
III. Conduct the 7 Joint Conference of Taiwan and Japan on Medical
Products Regulation
In order to implement the Taiwan and Japan medical products regulation cooperation
framework arrangement, the Joint Conference of Taiwan and Japan on Medical Products
Regulation was held in Taipei on October 1, 2019. For medical devices, the industry and
government representatives of both sides shared regulations on in vitro diagnostic medical
devices and priority review mechanism. Several topics were discussed extensively, including
guidance on medical device cybersecurity, review focus of in vitro diagnostic medical devices
and development trend of products, post-market supervision and regulatory mechanism for high-
ULVN PHGLFDO GHYLFHV DQG VLPSOL¿HG VXEPLVVLRQ IRU PHGLFDO GHYLFH UHJLVWUDWLRQ
IV. Conduct the Conference on International Medical Device Regulations in
South East Asia and Brazil
The “Conference on International Medical Device Regulations in South East Asia and
Brazil” was held at the International Convention Center of National Taiwan University Hospital
on August 12, 2019. Representatives from Singapore, Thailand, and Brazil were invited to share
their medical device regulations.
75
